Aridis Pharmaceuticals
Leading the creation of transformative, first-in-class anti-infectives for life-threatening respiratory infections
Los Gatos, United States
21 employees
Post-IPO Equity
Total: $81.74M
Biotechnology, Creator Economy +2
General Information
Los Gatos, United States
BounceWatch is an independent company data service, not affiliated with Aridis Pharmaceuticals. To contact Aridis Pharmaceuticals, visit aridispharma.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Aridis Pharmaceuticals compare?
A PDF of Aridis Pharmaceuticals and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Aridis Pharmaceuticals soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
From the desk
Is Aridis Pharmaceuticals on your competitive set?
Our desk can watch it and brief you on every move: hiring, funding, leadership, product and pricing.
Book a 7-day ReadoutDiscover More
United States Market
Biotechnology
About Aridis Pharmaceuticals
Business keywords: late-stage clinical development, antibacterial, antivirals, proprietary technology platforms, antimicrobial resistant bacteria, add-on treatments, antibody-producing B-cells, monoclonal antibodies, human origin, genetic engineering, infectious disease, cell line engineering, inhalation therapy
Funding Rounds & Investors (12)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Post IPO Equity | $2.28M | - |
|
14 Mar 2023 |
| Post IPO Equity | $4.85M | 1 |
|
12 Dec 2022 |
| Grant | Undisclosed | 1 |
|
27 Jan 2022 |
| Post IPO Equity | $25.00M | - |
|
02 Aug 2021 |
| Grant | $4.60M | 1 |
|
04 Dec 2018 |
| Venture Round | Undisclosed | 1 |
|
06 Jun 2018 |
| Grant | $2.90M | 1 |
|
09 Jan 2017 |
| Venture Round | $13.64M | - |
|
12 Dec 2016 |
| Venture Round | $15.22M | - |
|
19 Aug 2016 |
| Debt Financing | $3.00M | - |
|
04 Nov 2015 |
Aridis Pharmaceuticals Alternatives & Competitors
View All Alternatives
Delivering Novel Anti-Infectives
...focused on discovering & developing differentiated biologic therapies for life-threatening, drug-...
Phico Therapeutics is a biotechnology company advancing the war on antibiotic resistance with engine...
FAQ About Aridis Pharmaceuticals
Source: BounceWatch company record for Aridis Pharmaceuticals, https://bouncewatch.com/company/aridis-pharmaceuticals, updated 9 June 2026. When citing, please name BounceWatch and link this page.
